Literature DB >> 27162616

Pulmonary vascular morphology as an imaging biomarker in chronic thromboembolic pulmonary hypertension.

F N Rahaghi1, J C Ross2, M Agarwal1, G González2, C E Come1, A A Diaz1, G Vegas-Sánchez-Ferrero2, A Hunsaker2, R San José Estépar2, A B Waxman1, G R Washko1.   

Abstract

Patients with chronic thromboembolic pulmonary hypertension (CTEPH) have morphologic changes to the pulmonary vasculature. These include pruning of the distal vessels, dilation of the proximal vessels, and increased vascular tortuosity. Advances in image processing and computer vision enable objective detection and quantification of these processes in clinically acquired computed tomographic (CT) scans. Three-dimensional reconstructions of the pulmonary vasculature were created from the CT angiograms of 18 patients with CTEPH diagnosed using imaging and hemodynamics as well as 15 control patients referred to our Dyspnea Clinic and found to have no evidence of pulmonary vascular disease. Compared to controls, CTEPH patients exhibited greater pruning of the distal vasculature (median density of small-vessel volume: 2.7 [interquartile range (IQR): 2.5-3.0] vs. 3.2 [3.0-3.8]; P = 0.008), greater dilation of proximal arteries (median fraction of blood in large arteries: 0.35 [IQR: 0.30-0.41] vs. 0.23 [0.21-0.31]; P = 0.0005), and increased tortuosity in the pulmonary arterial tree (median: 4.92% [IQR: 4.85%-5.21%] vs. 4.63% [4.39%-4.92%]; P = 0.004). CTEPH was not associated with dilation of proximal veins or increased tortuosity in the venous system. Distal pruning of the vasculature was correlated with the cardiac index (R = 0.51, P = 0.04). Quantitative models derived from CT scans can be used to measure changes in vascular morphology previously described subjectively in CTEPH. These measurements are also correlated with invasive metrics of pulmonary hemodynamics, suggesting that they may be used to assess disease severity. Further work in a larger cohort may enable the use of such measures as a biomarker for diagnostic, phenotyping, and prognostic purposes.

Entities:  

Keywords:  arterial; chronic thromboembolic pulmonary hypertension; computed tomography; tortuosity

Year:  2016        PMID: 27162616      PMCID: PMC4860553          DOI: 10.1086/685081

Source DB:  PubMed          Journal:  Pulm Circ        ISSN: 2045-8932            Impact factor:   3.017


  21 in total

1.  Measurement and classification of retinal vascular tortuosity.

Authors:  W E Hart; M Goldbaum; B Côté; P Kube; M R Nelson
Journal:  Int J Med Inform       Date:  1999 Feb-Mar       Impact factor: 4.046

2.  Riociguat for pulmonary hypertension.

Authors:  Hossein-Ardeschir Ghofrani; Gerald Simonneau; Lewis J Rubin
Journal:  N Engl J Med       Date:  2013-12-05       Impact factor: 91.245

3.  Computed tomographic measures of pulmonary vascular morphology in smokers and their clinical implications.

Authors:  Raúl San José Estépar; Gregory L Kinney; Jennifer L Black-Shinn; Russell P Bowler; Gordon L Kindlmann; James C Ross; Ron Kikinis; Meilan K Han; Carolyn E Come; Alejandro A Diaz; Michael H Cho; Craig P Hersh; Joyce D Schroeder; John J Reilly; David A Lynch; James D Crapo; J Michael Wells; Mark T Dransfield; John E Hokanson; George R Washko
Journal:  Am J Respir Crit Care Med       Date:  2013-07-15       Impact factor: 21.405

4.  Vascular and right ventricular remodelling in chronic thromboembolic pulmonary hypertension.

Authors:  Marion Delcroix; Anton Vonk Noordegraaf; Elie Fadel; Irene Lang; Gérald Simonneau; Robert Naeije
Journal:  Eur Respir J       Date:  2012-08-16       Impact factor: 16.671

5.  Prediction of hemodynamic improvement after pulmonary endarterectomy in chronic thromboembolic pulmonary hypertension using non-invasive imaging.

Authors:  Bastiaan E Schölzel; Martijn C Post; Alexander van de Bruaene; Steven Dymarkowski; Wim Wuyts; Bart Meyns; Werner Budts; Marion Delcroix
Journal:  Int J Cardiovasc Imaging       Date:  2014-08-22       Impact factor: 2.357

6.  Prognostic relevance of pulmonary arterial compliance in patients with chronic heart failure.

Authors:  Paolo Pellegrini; Andrea Rossi; Michele Pasotti; Claudia Raineri; Mariantonietta Cicoira; Stefano Bonapace; Frank Lloyd Dini; Pier Luigi Temporelli; Corrado Vassanelli; Rebecca Vanderpool; Robert Naeije; Stefano Ghio
Journal:  Chest       Date:  2014-05       Impact factor: 9.410

Review 7.  Coagulation and the vessel wall in pulmonary embolism.

Authors:  Sherin Alias; Irene M Lang
Journal:  Pulm Circ       Date:  2013-12       Impact factor: 3.017

8.  The WHO classification of pulmonary hypertension: A case-based imaging compendium.

Authors:  John J Ryan; Thenappan Thenappan; Nancy Luo; Thanh Ha; Amit R Patel; Stuart Rich; Stephen L Archer
Journal:  Pulm Circ       Date:  2012 Jan-Mar       Impact factor: 3.017

9.  Defective angiogenesis delays thrombus resolution: a potential pathogenetic mechanism underlying chronic thromboembolic pulmonary hypertension.

Authors:  Sherin Alias; Bassam Redwan; Adelheid Panzenboeck; Max P Winter; Uwe Schubert; Robert Voswinckel; Maria K Frey; Johannes Jakowitsch; Arman Alimohammadi; Lukas Hobohm; Andreas Mangold; Helga Bergmeister; Maria Sibilia; Erwin F Wagner; Eckhard Mayer; Walter Klepetko; Thomas J Hoelzenbein; Klaus T Preissner; Irene M Lang
Journal:  Arterioscler Thromb Vasc Biol       Date:  2014-02-13       Impact factor: 8.311

10.  Quantification of tortuosity and fractal dimension of the lung vessels in pulmonary hypertension patients.

Authors:  Michael Helmberger; Michael Pienn; Martin Urschler; Peter Kullnig; Rudolf Stollberger; Gabor Kovacs; Andrea Olschewski; Horst Olschewski; Zoltán Bálint
Journal:  PLoS One       Date:  2014-01-31       Impact factor: 3.240

View more
  19 in total

1.  Pulmonary vascular density: comparison of findings on computed tomography imaging with histology.

Authors:  Farbod N Rahaghi; Gemma Argemí; Pietro Nardelli; David Domínguez-Fandos; Pedro Arguis; Víctor I Peinado; James C Ross; Samuel Y Ash; Isaac de La Bruere; Carolyn E Come; Alejandro A Diaz; Marcelo Sánchez; George R Washko; Joan Albert Barberà; Raúl San José Estépar
Journal:  Eur Respir J       Date:  2019-08-15       Impact factor: 16.671

2.  Quantification of the Pulmonary Vascular Response to Inhaled Nitric Oxide Using Noncontrast Computed Tomography Imaging.

Authors:  Farbod Nicholas Rahaghi; Tilo Winkler; Puja Kohli; Pietro Nardelli; Berta Martí-Fuster; James C Ross; Ramya Radhakrishnan; Tyler Blackwater; Samuel Y Ash; Isaac de La Bruere; Alejandro A Diaz; Richard N Channick; R Scott Harris; George R Washko; Raúl San José Estépar
Journal:  Circ Cardiovasc Imaging       Date:  2019-12       Impact factor: 7.792

3.  Arterial Vascular Pruning, Right Ventricular Size, and Clinical Outcomes in Chronic Obstructive Pulmonary Disease. A Longitudinal Observational Study.

Authors:  George R Washko; Pietro Nardelli; Samuel Y Ash; Gonzalo Vegas Sanchez-Ferrero; Farbod N Rahaghi; Carolyn E Come; Mark T Dransfield; Ravi Kalhan; MeiLan K Han; Surya P Bhatt; J Michael Wells; Carrie Pistenmaa Aaron; Alejandro A Diaz; James C Ross; Michael J Cuttica; Wassim W Labaki; Gabriela Querejeta Roca; Amil M Shah; Kendra Young; Gregory L Kinney; John E Hokanson; Alvar Agustí; Raúl San José Estépar
Journal:  Am J Respir Crit Care Med       Date:  2019-08-15       Impact factor: 21.405

4.  Image-based scaling laws for somatic growth and pulmonary artery morphometry from infancy to adulthood.

Authors:  Melody Dong; Weiguang Yang; John S Tamaresis; Frandics P Chan; Evan J Zucker; Sahana Kumar; Marlene Rabinovitch; Alison L Marsden; Jeffrey A Feinstein
Journal:  Am J Physiol Heart Circ Physiol       Date:  2020-07-03       Impact factor: 4.733

5.  Nanoparticle-Facilitated Gene Delivery in Congenital Pulmonary Vascular Disease: Roadmap for Other Forms of Pulmonary Hypertension.

Authors:  Jane A Leopold
Journal:  Circulation       Date:  2021-08-16       Impact factor: 39.918

6.  Loss of Pulmonary Vascular Volume as a Predictor of Right Ventricular Dysfunction and Mortality in Acute Pulmonary Embolism.

Authors:  Jasleen Minhas; Pietro Nardelli; Syed Moin Hassan; Nadine Al-Naamani; Eileen Harder; Samuel Ash; Gonzalo Vegas Sánchez-Ferrero; Stefanie Mason; Andetta R Hunsaker; Gregory Piazza; Samuel Z Goldhaber; Aaron B Waxman; Steven M Kawut; Raúl San José Estépar; George R Washko; Farbod N Rahaghi
Journal:  Circ Cardiovasc Imaging       Date:  2021-09-21       Impact factor: 8.589

7.  Pulmonary Artery-Vein Classification in CT Images Using Deep Learning.

Authors:  Pietro Nardelli; Daniel Jimenez-Carretero; David Bermejo-Pelaez; George R Washko; Farbod N Rahaghi; Maria J Ledesma-Carbayo; Raul San Jose Estepar
Journal:  IEEE Trans Med Imaging       Date:  2018-05-04       Impact factor: 10.048

8.  Arterial vascular volume changes with haemodynamics in schistosomiasis-associated pulmonary arterial hypertension.

Authors:  Farbod N Rahaghi; Joan F Hilton; Ricardo A Corrêa; Camila Loureiro; Jaquelina S Ota-Arakaki; Carlos G Y Verrastro; Michael H Lee; Claudia Mickael; Pietro Nardelli; David A Systrom; Aaron B Waxman; George R Washko; Raúl San José Estépar; Brian B Graham; Rudolf K F Oliveira
Journal:  Eur Respir J       Date:  2021-05-06       Impact factor: 16.671

Review 9.  Optimizing the diagnosis and assessment of chronic thromboembolic pulmonary hypertension with advancing imaging modalities.

Authors:  Seth Kligerman; Albert Hsiao
Journal:  Pulm Circ       Date:  2021-05-24       Impact factor: 3.017

10.  A multiscale model of vascular function in chronic thromboembolic pulmonary hypertension.

Authors:  Mitchel J Colebank; M Umar Qureshi; Sudarshan Rajagopal; Richard A Krasuski; Mette S Olufsen
Journal:  Am J Physiol Heart Circ Physiol       Date:  2021-06-18       Impact factor: 5.125

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.